Investigating how a specific molecule affects inflammation in the brain
Role of the neurovascular molecule Wnt in regulating CNS inflammatory responses
This study is looking at how a molecule called Wnt affects the immune system in the brain during conditions like multiple sclerosis, with the hope of finding new ways to help people with these inflammatory diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Cincinnati NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-10875627 on NIH RePORTER |
What this research studies
This research focuses on understanding how the Wnt molecule influences the immune response in the central nervous system, particularly during inflammatory diseases like multiple sclerosis. By studying animal models, the researchers aim to uncover the mechanisms through which Wnt signaling can either promote inflammation or aid in repair processes. The project involves analyzing gene expression in brain lesions to determine how Wnt affects immune cell behavior and interactions. Patients may benefit from insights gained that could lead to new treatments for CNS inflammatory conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with multiple sclerosis or other CNS inflammatory conditions.
Not a fit: Patients with non-inflammatory neurological disorders may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to novel therapies that improve treatment outcomes for patients with central nervous system inflammatory diseases.
How similar studies have performed: Previous research has shown that targeting immune regulation in the CNS can lead to significant advancements in treatment, suggesting this approach has potential for success.
Where this research is happening
Cincinnati, United States
- University of Cincinnati — Cincinnati, United States (Active)
Researchers
- Principal investigator: Ifergan, Igal — University of Cincinnati
- Study coordinator: Ifergan, Igal
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.